• Facial Surgery

    "I am excited to announce that I will be continuing care for Dr. Peter A. Adamson’s patients after the closure of his surgical practice. I have seen patients at Adamson MD Associates for many years and will continue to do so, providing the best possible care. Click the button below to learn more about me."

    Learn More

Xeomin Toronto

What is Xeomin?

Xeomin® is a form of botulinum toxin type A. This is the same toxin that is found in Botox®, but unlike Botox®, Xeomin® is free of complexing proteins. For both doctors and patients, the significance of this difference is not fully understood.

Xeomin Cosmetic is a treatment used in adults to reduce the appearance of moderate to severe frown lines. Like Botox Cosmetic, it is injected with very small needles into the muscle region that needs to be treated, causing the active molecule to bind with its target muscle. The binding has a very precise relaxing effect that causes the muscle to move less, therefore smoothing out the skin.

How long does Xeomin® last?

The length of time each Xeomin® treatment lasts largely depends on the individual being treated. Factors such as one’s anatomy, the size of the muscles being treated, as well as the dose of Xeomin® being used all affect the duration of the treatment. Recent studies indicate the effects of Xeomin® are similar to those of Botox® depending on the dosage, or units used. On average, patients choose to have repeat treatments every 3 to 4 months. This frequency is just an average, and therefore some patients may need more frequent treatments while others will need less frequent treatments.

Xeomin (incobotulinumtoxinA), is US FDA approved alternative to Botox and is used for the treatment of frown lines, crow’s feet and forehead wrinkles.

Side effects include minor bleeding and bruising at the injection site and allergic reactions such as itching, swelling or shortness of breath. The risk of these side effects are thoroughly discussed at the time of your consultation with Dr. Gantous.

Get a Consultation




captcha
I agree to the Terms of Use